- Report
- March 2025
- 200 Pages
Global
From €4154EUR$4,490USD£3,493GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3469EUR$3,750USD£2,917GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €463EUR$500USD£389GBP
- Report
- May 2023
- 121 Pages
Global
From €3500EUR$4,053USD£3,047GBP
Akynzeo is a combination of two drugs, netupitant and palonosetron, used to treat nausea and vomiting caused by chemotherapy in patients with cancer. It is a type of oncology drug, which is a medication used to treat cancer. Akynzeo works by blocking the action of certain chemicals in the body that can cause nausea and vomiting. It is available in capsule form and is taken orally.
Akynzeo is used to prevent nausea and vomiting in patients receiving chemotherapy for cancer. It is also used to prevent nausea and vomiting in patients receiving radiation therapy for cancer. Akynzeo is not used to treat nausea and vomiting caused by other conditions.
Akynzeo is marketed by several pharmaceutical companies, including Helsinn, Eisai, and Teva Pharmaceuticals. It is available in the United States, Canada, Europe, and other countries. Akynzeo is also available in generic form. Show Less Read more